NASA Licensed Tech Leverage the NASA-licensed core technology and NASA collaboration to solidify credibility with hospitals, medical device manufacturers, and government programs; use as a differentiator when pursuing SBIR/STTR funding, research partnerships, or procurement contracts for anti-infection prosthetic solutions.

Anti-Biofilm Advantage Offers up to 90% reduction in pathogenic bacteria adhesion on implanted devices without antibiotics, presenting a strong value proposition to reduce infection rates, antibiotic use, and hospital readmissions; target orthopedic and dental implant manufacturers, surgical centers, and health systems seeking infection control and patient safety improvements.

Prosthetic Market Fit Laser Surface Texturing technology complements the core anti-biofilm solution; opportunity to integrate coating or processing into prosthetic manufacturing or supplier qualification programs, enabling joint product offerings for implants with biofilm resistance.

Strategic Partnerships Lean team size creates agility but limited selling capacity; pursue partnerships with contract manufacturers, CROs, distributors, and strategic investors to scale sales channels, run pilots, and accelerate regulatory and clinical validation, especially with early adopters in orthopedics and dental implants.

Growth and Validation Revenue traction indicates initial market interest; couple this with NASA licensing as a differentiator to attract larger medical device players and secure pilots/case studies; leverage government and space-health partnerships for funded projects and expanded market opportunities.